SCHEMBL6945569

SCHEMBL6945569

N#Cc1c(N2CCc3ccccc3CC2)nc(NCC(F)(F)F)n(CC(F)(F)F)c1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.37
KDM4E B2RXH2 8/20 0.37
MAPT P10636 4/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
HTT P42858 4/20 0.37
POLB P06746 2/20 0.37
GAA P10253 1/20 0.37
HIF1A Q16665 1/20 0.37
GRM2 Q14416 1/20 0.36
HPGD P15428 5/20 0.35
HSD17B10 Q99714 3/20 0.35
TP53 P04637 2/20 0.35
NPSR1 Q6W5P4 3/20 0.34
PIK3CD O00329 1/20 0.34
MAPK1 P28482 3/20 0.33
TSHR P16473 2/20 0.33
PLK1 P53350 1/20 0.33
CSNK2A1 P68400 1/20 0.33
CASP1 P29466 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6954163 0.88 MAPT (0.39) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL6947600 0.83 GRM2 (0.40) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL6950991 0.81 GRM2 (0.37) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL6947484 0.80 ALDH1A1 (0.42) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL6947649 0.80 ALDH1A1 (0.41) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL6947710 0.79 KDM4E (0.38) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL6953008 0.77 GRM2 (0.38) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL6950841 0.76 ALDH1A1 (0.45) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL6956201 0.76 KDM4E (0.41) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL6950993 0.76 ALDH1A1 (0.40) ALDH1A1KDM4EMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed